Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools


You are here: Home
7 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Gene inactivation drives spread of melanoma
by Mary Ruth published Jun 11, 2012 last modified Jun 15, 2012 12:57 PM — filed under: , ,
Chapel Hill, NC – Why do some cancers spread rapidly to other organs and others don’t metastasize? A team of UNC researchers led by Norman Sharpless, MD, have identified a key genetic switch that determines whether melanoma, a lethal skin cancer, spreads by metastasis.
Located in News / 2012 News
Genetic pattern predicts response, metastasis in melanoma
by Mary Ruth published Jun 14, 2012 last modified Jun 14, 2012 03:47 PM — filed under: , ,
A gene known to be mutated in many different cancers, but thought to be relatively unimportant in melanoma, may be a key indicator of how the disease will respond to radiation therapy and whether it will spread.
Located in News / 2012 News
Multidisciplinary research urged for optimal melanoma surgery
by Mary Ruth published Oct 25, 2011 last modified Oct 25, 2011 09:28 AM — filed under: , ,
UNC surgical oncologist co-authors Lancet editorial
Located in News / 2011 News
New Treatments for Melanoma
by Mary Ruth published Jun 14, 2011 last modified Aug 28, 2013 07:36 PM — filed under:
This free community Lunch and Learn Workshop will be presented by Dr. Frances Collichio, an associate professor of medicine in the division of hematology and oncology in the UNC School of Medicine and a member of UNC Lineberger Comprehensive Cancer Center.
Located in Events
P Rex-1 protein key to melanoma metastasis
by Mary Ruth published Nov 22, 2011 last modified Nov 22, 2011 11:22 AM — filed under: , ,
UNC scientists contribute cell studies and protein expression analysis
Located in News / 2011 News
Study reveals new molecular target for melanoma treatment
by Mary Ruth published Aug 17, 2012 last modified Aug 22, 2012 03:42 PM — filed under: , ,
Chapel Hill, NC – A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood.
Located in News / 2012 News
University Cancer Research Fund Grant Teams Lineberger Faculty with Renaissance Computing Institute to Battle Skin Cancer
by Mary Ruth published Mar 13, 2008 last modified Oct 12, 2011 09:49 AM — filed under: , , ,
CHAPEL HILL, NC - A new collaboration between melanoma researchers in the School of Medicine at the University of North Carolina at Chapel Hill, the Renaissance Computing Institute (RENCI), and researchers from the departments of computer science, epidemiology, biostatistics, and statistics and operations research at UNC Chapel Hill aims to use image analysis techniques to aid doctors in the fight against melanoma, the most serious form of skin cancer.
Located in News / 2011 News